ArticleCancer chemotherapy and pharmacology2013

Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer.

Francisco J Esteva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.